Medical Observer - Information is our Prescription

About Us      Contact Us      Our Services      Press Room      Careers

 

Front-page

Heard and Read

In the News

Features

New Frontiers

Genetics

Cancer Watch

Country Report

UN Health

Industry News

Drug Updates

Organized Medicine

Off Duty

 

CME Calendar

Local
Conventions

Overseas
Conventions

powered by: FreeFind

March 2008

January - February 2008

More Issues
Medical Tourism Asia

Mailing List
Receive updates from Medical Observer

Name
Email
Specialty
PRC Lic.

 
 
 
 
 

Neurology

Galantamine Edge in AD

Galantamine (Reminyl) exhibits a superior treatment profile than donepezil (Aricept) for patients with Alzheimer's Disease, according to results of the first one-year head to head study of the two drugs.

More on this Story

Piracetam Is Neuroprotective

Cerebrovascular disease is now the leading cause of morbidity and mortality worldwide. It is also the most common cause of chronic disability.  

More on this Story

Recovering from Ischemic Stroke

Oral citicoline ups odds of favorable outcome by 33% after 12 weeks of treatment, meta-analysis shows.  

More on this Story

 

Updated last April 20, 2008 , Developed and Maintained by JML Internet Solutions
Best viewed with Microsoft Internet Explorer 5 and up at 800x600 resolution

Notice: The articles in this website are meant for information and education purposes only and are not intended to encourage self-diagnosis and self-medication. Readers should consult their physicians for professional medical advice. 

Copyright © 2006, Medical Observer. All rights reserved.